FDA Inspection
ACS Dobfar S.p.A.ACS Dobfar S.p.A. – FDA Inspection, Mar 18, 2014
Record Details
This FDA Inspection record concerns ACS Dobfar S.p.A., with an inspection on March 18, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- ACS Dobfar S.p.A.
- Inspection Date
- March 18, 2014
- Product Type
- Drugs
View Company Profile
ID · 11090c73-abed-4fd3-88e5-2aa3e0451cee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 873439
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of ACS Dobfar S.p.A.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 8, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ACS Dobfar S.p.A.
- FDA Inspection 1273719 - 2023-10-27
- FDA Inspection 1122752 - 2019-04-19
- FDA Inspection 1056132 - 2018-06-19
- FDA Inspection 973195 - 2016-05-20
- FDA Inspection 751609 - 2011-07-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.